Upregulation of thbs1 is related to immunity and chemotherapy resistance in gastric cancer

42Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Purpose: Thrombospondin 1 (THBS1) is an endogenous inhibitor of angiogenesis, but it also promotes tumor invasion, metastasis, and immune response in the tumor environment. Previous research has found that THBS1 is highly expressed in many tumors and has a negative correlation with tumor prognosis. However, research on the relationship between THBS1 and immune infiltration in GC is less well documented, and the objective of our study was to investigate the role of THBS1 expression in GC. Patients and Methods: The expression of THBS1 in GC was analyzed by Oncomine, TIMER, TGCA, GEO and IHC staining. Analysis of the signaling pathways associated with THBS1 expression in GC uses GSEA. The relationship between THBS1 expression and immune infiltration was analyzed by the ESTIMATE algorithm, single-cell transcriptome analysis, TIMER2 database and CIBERSORT algorithm. Finally, the relationship between THBS1 expression and drug sensitivity was analyzed by the CellMiner database. Results: THBS1 was overexpressed in GC and was associated with poor prognosis, and high THBS1 expression was an independent risk factor. GSEA results showed that high THBS1 expression in GC was associated with tumorigenesis, adhesion, and significant immune enrichment. THBS1 expression was most strongly correlated with tumor-associated macro-phages (TAMs), M2 macrophages and cancer-associated fibroblast (CAFs) in GC. THBS1 expression positively correlates with most immune checkpoint members, suggesting that THBS1 may play an important role in the tumor microenvironment. THBS1 overexpression was negatively correlated with some drug sensitivities, such as Oxaliplatin. Conclusion: Upregulation of THBS1 was positively correlated with poor prognosis and immunosuppression in GC and negatively correlated with anticancer drug sensitivity, suggesting that THBS1 may serve as a potential target for the treatment of GC.

References Powered by Scopus

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

78192Citations
N/AReaders
Get full text

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

36521Citations
N/AReaders
Get full text

Robust enumeration of cell subsets from tissue expression profiles

8559Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The role of cancer-associated fibroblasts in tumorigenesis of gastric cancer

45Citations
N/AReaders
Get full text

Immunometabolic attributes and mitochondria-associated signaling of Tumor-Associated Macrophages in tumor microenvironment modulate cancer progression

31Citations
N/AReaders
Get full text

Mimicking Tumor Cell Heterogeneity of Colorectal Cancer in a Patient-derived Organoid-Fibroblast Model

25Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Zhang, X., Huang, T., Li, Y., & Qiu, H. (2021). Upregulation of thbs1 is related to immunity and chemotherapy resistance in gastric cancer. International Journal of General Medicine, 14, 4945–4957. https://doi.org/10.2147/IJGM.S329208

Readers over time

‘21‘22‘23‘24036912

Readers' Seniority

Tooltip

Researcher 4

57%

PhD / Post grad / Masters / Doc 2

29%

Professor / Associate Prof. 1

14%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 5

83%

Agricultural and Biological Sciences 1

17%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free
0